Healing Statements and Their Effect on Post Operative Pain (PHSPOPC)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02502357 |
Recruitment Status :
Completed
First Posted : July 20, 2015
Last Update Posted : August 21, 2020
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Pelvic Organ Prolapse | Other: Healing Statements | Not Applicable |
This is a randomized controlled trial of women undergoing vaginal hysterectomy with minimally invasive sacrocolpopexy. Eligible patients will be approached for study participation after they have decided to proceed with the vaginal hysterectomy with minimally invasive sacrocolpopexy. After enrollment, demographics including age, race, prolapse stage, and medical history will be collected. Before vaginal hysterectomy with minimally invasive sacrocolpopexy in the OR, they will be randomized to the group that will be read healing statements or to the group without healing statements. Women randomized to the healing statement group will have the following statements read to them by a trained research staff member, using Peggy Huddleston's technique. Before the patient is placed under general anesthesia, the study staff member will repeat 5 times:
"Following this operation, [the participant] will feel very comfortable and [the participant] will heal very well"
Toward the end of the surgery, the study staff member will say 5 times:
"The operation has gone very well." "Following the operation, [the participant] will be hungry. [The participant] will be thirsty and urinate easily."
Prior to reading these statements to the patient, the research staff member will listen to a previously recorded audio sample of how the statements should be read with regard to tone of voice and attitude.
Patients will then fill out the VAS pain scale 6 and 24 hours after surgery. Pain medication use, dosage, type of medication will be assessed by examining electronic medical records. Time to pass void trial and time to first bowel movement will be recorded on paper and brought to the patient's 2-week follow up visit. Nausea will be assessed 6 and 24 hours after surgery using the Postoperative Nausea and Vomiting (PONV) Intensity Scale. Patients will be given standard post-operative instructions for a vaginal hysterectomy with minimally invasive sacrocolpopexy, and be told to come to the clinic in 2 weeks for a follow up visit. During this time, the will be told to keep a daily diary of pain medication use including name, dosage, and amount taken. At the 2-week visit, the patient will fill out another VAS pain scale and PFDI-20 and their pain medication diaries will be collected. The patient's overall sense of recovery will be assessed using the PGI. Once the data is collected, statistical analysis will be performed.
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 32 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Double (Participant, Outcomes Assessor) |
Masking Description: | simple randomization |
Primary Purpose: | Prevention |
Official Title: | The Power of Healing Statements on Post Operative Pain Control: A Randomized Controlled Trial |
Actual Study Start Date : | July 2015 |
Actual Primary Completion Date : | March 8, 2016 |
Actual Study Completion Date : | September 14, 2016 |
Arm | Intervention/treatment |
---|---|
Experimental: Healing Statements
Patients in the healing statements group will be read healing statements during anesthesia induction, prior to undergoing surgery.
|
Other: Healing Statements
Before the patient in the experimental group is placed under general anesthesia, the study staff member will repeat 5 times: "Following this operation, [the participant] will feel very comfortable and [the participant] will heal very well." Toward the end of the surgery, the study staff member will say 5 times: "The operation has gone very well." "Following the operation, [the participant] will be hungry. [The participant] will be thirsty and urinate easily." |
No Intervention: No Healing Statements
Patients in the no healing statements group will not be read healing statements during anesthesia induction prior to undergoing surgery. They will receive standard of care.
|
- Baseline Pain (analyzed by VAS Numeric Pain Distress Scale) [ Time Frame: baseline ]Pain
- Post Operative Pain (analyzed by VAS Numeric Pain Distress Scale) [ Time Frame: 6 hours after surgery ]Pain
- Post Operative Pain (analyzed by VAS Numeric Pain Distress Scale) [ Time Frame: 24 hours after surgery ]Pain
- Post Operative Pain (analyzed by VAS Numeric Pain Distress Scale) [ Time Frame: 2 weeks after surgery ]Pain
- Post operative Nausea and Vomiting (analyzed by Post-Operative Nausea and Vomiting Intensity Scale) [ Time Frame: 6 hours after surgery and 24 hours after surgery ]Nausea and Vomiting
- Time to First Bowel Movement [ Time Frame: Followed for 2 weeks after surgery ]Bowel Movement
- Time to Pass Void Trial (Urination) [ Time Frame: Followed for 2 weeks after surgery ]Urination
- Patient Perception of Improvement [ Time Frame: 2 weeks after surgery ]Patient Perception of Improvement measured by Patient Global Perception of Improvement Scale

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Women who undergo vaginal hysterectomy with minimally invasive sacrocolpopexy
- Age ≥18 years
- English speaking
- Available for 2 week follow up
- Able to complete study questionnaires
Exclusion Criteria:
- History of chronic pain prior to surgery
- Pain during intercourse or in lower abdomen or genital region at baseline prior to index surgery (identified if patient answers yes to question 20 on the Pelvic Floor Distress Inventory-20)
- Hearing impairment
- Pregnancy by self-report or positive pregnancy test
- Active pelvic infection, herpes, candidiasis
- Indication for surgery is due to neoplasm
- History of pain syndromes including fibromyalgia, interstitial cystitis, dysmenorrhea, and depression

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02502357
United States, District of Columbia | |
Washington Hospital Center | |
Washington, District of Columbia, United States, 20010 |
Principal Investigator: | Cheryl Iglesia, MD | Medstar Washington Hospital Center |
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: | Medstar Health Research Institute |
ClinicalTrials.gov Identifier: | NCT02502357 |
Other Study ID Numbers: |
2015-043 |
First Posted: | July 20, 2015 Key Record Dates |
Last Update Posted: | August 21, 2020 |
Last Verified: | August 2020 |
pain control healing statements pelvic prolapse |
Prolapse Pain, Postoperative Pelvic Organ Prolapse Pathological Conditions, Anatomical |
Postoperative Complications Pathologic Processes Pain Neurologic Manifestations |